ScholarLens Back to search
2010•China Practical MedicineRequires access

Observation between propafenone and amiodarone in treating paroxysmal supraventricular tachycardia

LI Zhu-a

Open publisher page 0 citations

Abstract

Objective To observe the effects of Propafenone and Amiodarone in treating paroxysmal supraventricular tachycardia (PSVT). Methods 36 patients of PSVT were treated with Propafenone and the other 28 patients were treated with Amiodarone. Results The termination rate of PSVT was 100% in Propafenone and 89. 3% (25 /28) in Amiodarone respectively. Cardioversion time: Propafenone (12. 6 ± 6. 7) min was significantly shorter than Amiodarone (29. 5 ± 11. 3) min(P 0. 01). Conclusion Propafenone and Amiodarone both have good effects in treating PSVT,Propafenone takes effect faster,but better for patients with normal cardiac function and without serious organic heart diseases. Amiodarone takes effect slower,but with wide indications. For patients with organic heart diseases,myocardial ischemia or heart failure,Amiodarone can be preferred.

About this research paper

What this paper is about

Objective To observe the effects of Propafenone and Amiodarone in treating paroxysmal supraventricular tachycardia (PSVT). Methods 36 patients of PSVT were treated with Propafenone and the other 28 patients were treated with Amiodarone. Results The termination rate of PSVT was 100% in Propafenone and 89. 3% (25 /28) in Amiodarone respectively. Cardioversion time: Propafenone (12. 6 ± 6. 7) min was significantly shorter than Amiodarone (29. 5 ± 11. 3) min(P 0. 01). Conclusion Propafenone and Amiodarone both have good effects in treating PSVT,Propafenone takes effect faster,but better for patients with normal cardiac function and without serious organic heart diseases. Amiodarone takes effect slower,but with wide indications. For patients with organic heart diseases,myocardial ischemia or heart failure,Amiodarone can be preferred.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of Propafenone and Amiodarone in treating paroxysmal supraventricular tachycardia (PSVT). Methods 36 patients of PSVT were treated with Propafenone and the other 28 patients were treated with Amiodarone. Results The termination rate of PSVT was 100% in Propafenone and 89. 3% (25 /28) in Amiodarone respectively. Cardioversion time: Propafenone (12. 6 ± 6. 7) min was significantly shorter than Amiodarone (29. 5 ± 11. 3) min(P 0. 01). Conclusion Propafenone and Amiodarone both have good effects in treating PSVT,Propafenone takes effect faster,but better for patients with normal cardiac function and without serious organic heart diseases. Amiodarone takes effect slower,but with wide indications. For patients with organic heart diseases,myocardial ischemia or heart failure,Amiodarone can be preferred.

Key concepts: Propafenone, Amiodarone, Medicine, Paroxysmal supraventricular tachycardia, Cardiology, Cardioversion, Internal medicine, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Observation between propafenone and amiodarone in treating paroxysmal supraventricular tachycardia — Research Paper | ScholarLens